Ovation iX Iliac Stent Graft TV-IL1410160-JRecalls & reported problems
Endologix LLC · The Ovation iX™ Iliac Limbs are components of the Ovation Prime, Ovation iX, and Alto™ Abdominal Stent Graft Systems. The Ovation iX™ Iliac Limbs are comprised of a nitinol stent encapsulated in low-permeability PTFE. The iliac limbs are deployed into the leg sections of the aortic body. Additional iliac limbs may be used to extend the length of the device, where indicated. · Class 3 · Implant
All models of Ovation iX Iliac Stent Graft (66)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00850007370114), received between Aug 24, 2022 and Jun 16, 2023 — classified as 3 injuries.
The most frequently reported specific device problem is “Complete Blockage” (1 report).
3 other recalls cover devices cleared under the same FDA submission (P120006); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Complete Blockage1
- Improper or Incorrect Procedure or Method1
- Obstruction of Flow1
- Off-Label Use1
- Unintended Movement1
Patient problems
- Obstruction/Occlusion2
- Aneurysm1
- Clinical Endoleak1
- Failure of Implant1
- Rupture1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
InjuryJun 16, 2023Complete Blockage; Unintended Movement; Complete Blockage; Unintended Movement
THE PATIENT WAS BEING TREATED FOR AN ABDOMINAL AORTIC ANEURYSM (AAA) WITH THE ALTO STENT GRAFT SYSTEM. APPROXIMATELY THIRTY-ONE (31) DAYS POST INITIAL PROCEDURE AT ROUTINE FOLLOW-UP, IT WAS IDENTIFIED THAT THE LEFT LIMB OF THE STENT GRAFT HAD MIGRATED DOWNWARDS IN THE PATIENT'S BODY. THE PATIENT IS IN STABLE CONDITION. A RE-INTERVENTION IS PLANNED TO ADDRESS THE ISSUE, BUT SURGERY HAS NOT BEEN SCHEDULED. ADDITIONAL INFORMATION: THE INITIAL REPORT INDICATED A "LIMB WENT DOWN - MIGRATION" SCENARIO. HOWEVER, UPON A COMPREHENSIVE REVIEW OF THE COMPUTERIZED TOMOGRAPHY (CT) SCAN RESULTS, IT BECAME EVIDENT THAT THE INTENDED INTERPRETATION WAS THAT THE "LIMB WENT DOWN" IN THE CONTEXT OF OCCLUSION, RATHER THAN SIGNIFYING MIGRATION. THE OBJECTIVE FINDINGS FROM THE COMPUTERIZED TOMOGRAPHY (CT) SCAN CONDUCTED ON (B)(6), 2023, SHOW THE COMPLETE OCCLUSION OF THE LEFT LIMB. THIS CONCLUSION ALIGNS WITH THE CLINICAL SUMMARY, WHICH ALSO CONFIRMS THE OCCLUSION OF THE LEFT LIMB. THE IDENTIFIED CONTRIBUTING FACTORS SUGGEST THAT THE OCCURRENCE OF ANGULATION UPON AB'S LANDING LED TO THE OCCLUSION OF THE LEFT LIMB. THE PATIENT UNDERWENT A SECONDARY PROCEDURE DURING WHICH THE PHYSICIAN CHOSE TO PERFORM THE
Patient problems: Clinical Endoleak; Failure of Implant; Obstruction/Occlusion
MAUDE report 17144835 ↗InjuryMar 9, 2023Obstruction of Flow; Obstruction of Flow
THE PATIENT WAS IMPLANTED WITH THE ALTO STENT GRAFT SYSTEM TO TREAT AN ABDOMINAL AORTIC ANEURYSM (AAA). APPROXIMATELY ONE (1) YEAR POST INITIAL PROCEDURE, THE PATIENT HAD AN OCCLUSION OF THE RIGHT OVATION ILIAC LIMB DUE TO THE LIMB BEING IN A BEND IN THE ILIAC ARTERY AND THIS SHUT FLOW DOWN TO LIMB. IT WAS ALSO NOTED THAT THE LEFT SIDE HAD BECOME ANEURYSMAL. THE PHYSICIAN ELECTED TO TREAT THE PATIENT BY EXTENDING BOTH LIMBS TO SUCCESSFULLY RESOLVE THESE EVENTS. THE FINAL PATIENT STATUS WAS REPORTED AS DOING GOOD AND WAS RELEASED HOME.
Patient problems: Aneurysm; Obstruction/Occlusion
MAUDE report 16519001 ↗InjuryAug 24, 2022Off-Label Use; Improper or Incorrect Procedure or Method; Off-Label Use; Improper or Incorrect Procedure or Method
THE PATIENT WAS BEING TREATED FOR AN ABDOMINAL AORTIC ANEURYSM (AAA) WITH THE ALTO STENT GRAFT SYSTEM. REPORTEDLY, THE AORTIC NECK WAS 11MM, THERE WAS AN EXISTING UNDERSIZED SELF-EXPANDING STENT IN THE COMMON ILIAC ARTERY (CIA) AND LEFT EXTERNAL ILIAC ARTERY (EIA)/CIA WAS COMPLETELY OCCLUDED. PER THE SIZING SHEET THE LEFT CIA WAS OFF LABEL AS IT MEASURED AT 7MM AND SHOULD BE = 8MM & = 25MM. THE PHYSICIAN WAS ABLE TO CROSS THE LEFT ILIAC OCCLUSION WITH WIRES AND CATHETERS AND A RE-ENTRY DEVICE. THE GRAFT WAS PLACED AND WHEN POST BALLOONING THE LEFT LIMB THE CIA HYPO JUNCTION OF THE VESSEL RUPTURED. AN ADDITIONAL OVATION IX ILIAC LIMB WAS IMPLANTED TO COVER THE RUPTURED VESSEL; HOWEVER, THE RUPTURE WAS BEING FED RETROGRADE VIA COLLATERALS FROM THE RIGHT ILIAC SYSTEM CAUSING A SLOW LEAK. THE PHYSICIAN OPENED THE PATIENTS LEFT RETROPERITONEAL CAVITY TO EVACUATE THE HEMATOMA, SEWED AND CLIP THE LEFT HYPO. THIS WAS SUCCESSFUL. THE PATIENT HAD PALPABLE DISTAL PULSES, BOTH ILIACS SYSTEMS ARE PATENT AND THE ANEURYSM IS EXCLUDED. THE PATIENT WAS REPORTED TO BE STABLE POST-PROCEDURE AND WAS EXPECTED TO BE DISCHARGED ONE DAY POST PROCEDURE.
Patient problems: Rupture
MAUDE report 15287429 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under P120006. One submission often covers many models, so check the product and lot details in each record.
- Z-2263-2020 · May 6, 2020 · TerminatedOvation iX Abdominal Stent Graft Systems, REF: TV-AB2080-I, TV-AB2080-J, TV-AB2380-I, TV-AB2380-J, TV-AB2680-I, TV-AB2680-J, TV-AB2980-I, TV-AB2980-J, TV-AB3480-I, TV-AB3480-J
- Z-0125-2015 · Sep 20, 2014 · TerminatedOvation Prime Abdominal Stent Graft System - 29mm Aortic Body stent grafts. The TriVascular Ovation Prime Abdominal Stent Graft System is a low-profile endovascular device deliver
- Z-0288-2013 · Oct 19, 2012 · TerminatedTriVascular brand Fill Polymer Kit, Endovascular Graft, Aneurysm Treatment System, European Model Number: TVFP14-B, (in European distributor inventory only); PRODUCT Usage: The
Other System, Endovascular Graft, Aortic Aneurysm Treatment devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page